MARÍA ISABEL
TEJADA MÍNGUEZ
Investigadora hasta 2019
Hospital Clinic Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (8)
2020
-
Effect of AGG Interruptions on FMR1 Maternal Transmissions
Frontiers in Molecular Biosciences, Vol. 7
-
Molecular characterization of Spanish patients with MECP2 duplication syndrome
Clinical Genetics, Vol. 97, Núm. 4, pp. 610-620
2018
-
Clinical implication of FMR1 intermediate alleles in a Spanish population
Clinical Genetics, Vol. 94, Núm. 1, pp. 153-158
2014
-
Guía clínica de las enfermedades asociadas al gen FMR1: síndrome X frágil, insuficiencia ovárica primaria y síndrome de temblor-ataxia
Medicina Clinica, Vol. 142, Núm. 5, pp. 219-225
-
Molecular testing for fragile X: Analysis of 5062 tests from 1105 fragile X families - Performed in 12 clinical laboratories in Spain
BioMed Research International, Vol. 2014
2011
-
Intermediate FMR1 alleles and cognitive and/or behavioural phenotypes
European Journal of Human Genetics, Vol. 19, Núm. 8, pp. 921-923
2007
2006
-
Screening for MECP2 mutations in Spanish patients with an unexplained mental retardation
Clinical Genetics, Vol. 70, Núm. 2, pp. 140-144